Dyne Therapeutics to Participate in Upcoming Investor Conferences
WALTHAM, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that management is scheduled to participate in the following upcoming investor conferences:
- TD Cowen 46
thAnnual Health Care Conference, fireside chat on Wednesday, March 4, 2026 at 11:50 a.m. ET in Boston, MA
- 2026 Jefferies Biotech on the Beach Summit, hosting meetings on Tuesday, March 10 and Wednesday, March 11, 2026 in Miami, FL
- Stifel 2026 Virtual CNS Forum, virtual fireside chat on Tuesday, March 17, 2026 at 4:00 p.m. ET
A live webcast of each fireside chat will be available in the Investors & Media section of Dyne’s website and a replay will be accessible for 90 days.
About Dyne Therapeutics
Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as a preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities.
Contacts:
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
I'd Buy DoorDash (DASH), Says Jim Cramer

Amazon (AMZN)'s Doing Better Than People Think, Says Jim Cramer

UBS Lowers Unum Group (UNM) Forecast While Maintaining Neutral Rating

ServiceNow (NOW)'s CEO is Doing Everything He Can, Says Jim Cramer

